ArticleCardiovascular diabetology2012

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.

Bryan Wai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.